【Intro】CRTORTH CO., LTD - TAcc+


Company Introduction

CRYORTH BioMed started from a team composed of medicine and clinical research professionals. We focus on cryotherapy techniques and develop innovative cryosurgical devices for musculoskeletal tumors. Our mission is to treat tumors in a safer and more effective way- “until the last tumor is frozen.”

Before we established in 2020, We’ve gained a lot of experience in clinical issues and medical device development over the years. There were many excellent achievements in the Ministry of Science and Technology (MOST) programs and national accelerators. We keep focusing on medical unmet needs of cryosurgery and listening about professionals’experience. We strive for improving products efficiency to solve surgical problems and offer these medical devices with high safety and user-friendly design.

Brief description of main products or services 

Cryo-Gel- an Innovative cryosurgical solution for orthopedic surgeons.

Cryo-Gel is new type of cryogen and designed to treat the tiny and residual bone tumors after intralesional curettage. The features of Cryo-Gel are extremely-low temperature (-114℃) and semi-solid status. It can not only bring convenience for the surgeons and reduce risk of frozen injury but release massive cold energy contributing to cancellous cells apoptosis. This preparation system standardizes the manufacturing process of Cryo-Gel. With this creative approach, it enhances the current cryosurgery and health care quality.